Skip to main content
. 2017 Mar 9;8(16):27328–27338. doi: 10.18632/oncotarget.16033

Figure 5. Cumulative disease-specific survival as stratified by either (a) EBER mRNA expression in cancer cells and HPV coinfection (positive/all cases n=4/54, p=0.003) or (b) HPV/HSV-1 coinfection (positive/all cases n=3/60, p=0.016).

Figure 5